EGCG suppressed tumor growth based on an in vivo study through decreasing the expression of miR-25 and proteins linked with apoptosis, which was additional established by a reduction of Ki-67 and increase of pro-apoptotic PARP expression [156]. The gene discussed is MKI67; the disease is neoplasm.